|
Ojima, Iwao; Borella, Christopher P; Wu, Xinyuan et al. (2005) Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. J Med Chem 48:2218-28
|
|
Berleth, E S; Nadadur, S; Henn, A D et al. (1999) Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis. Cancer Res 59:5497-506
|
|
Huang, B G; Bobek, M (1998) Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines. Carbohydr Res 308:319-28
|
|
Ojima, I; Bounaud, P Y; Takeuchi, C et al. (1998) New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells. Bioorg Med Chem Lett 8:189-94
|
|
Ehrke, M J; Verstovsek, S; Pocchiari, S K et al. (1998) Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculation. Int J Cancer 76:579-86
|
|
Yin, M B; Guo, B; Voigt, W et al. (1998) Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein. Biochim Biophys Acta 1401:265-76
|
|
Ehrke, M J; Verstovsek, S; Ujhazy, P et al. (1998) Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunol Immunother 45:287-98
|
|
Sharma, A; Mayhew, E; Bolcsak, L et al. (1997) Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 71:103-7
|
|
Levasseur, L M; Greco, W R; Rustum, Y M et al. (1997) Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells. Cancer Chemother Pharmacol 40:495-505
|
|
Fogel-Petrovic, M; Kramer, D L; Vujcic, S et al. (1997) Structural basis for differential induction of spermidine/spermine N1-acetyltransferase activity by novel spermine analogs. Mol Pharmacol 52:69-74
|
Showing the most recent 10 out of 135 publications
